Data on COVID-19 Reported by Danny Wende and Colleagues (Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme): Coronavirus – COVID-19

2021 DEC 03 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx COVID-19 Daily -- New research on Coronavirus - COVID-19 is the subject of a report. According to news reporting from Wuppertal, Germany, by NewsRx journalists, research stated, “In this population-based cohort study, billing data from German statutory health insurance (BARMER, 10% of population) are used to develop a prioritisation model for COVID-19 vaccinations based on cumulative underlying conditions. Using a morbidity-based classification system, prevalence and risks for COVID-19-related hospitalisations, ventilations and deaths are estimated.”

The news correspondents obtained a quote from the research, “Trisomies, behavioural and developmental disorders (relative risk: 2.09), dementia and organic psychoorganic syndromes (POS) (2.23) and (metastasised) malignant neoplasms (1.99) were identified as the most important conditions for escalations of COVID-19 infection. Moreover, optimal vaccination priority schedules for participants are established on the basis of individual cumulative escalation risk and are compared to the prioritisation scheme chosen by the German Government. We estimate how many people would have already received a vaccination prior to escalation. Vaccination schedules based on individual cumulative risk are shown to be 85% faster than random schedules in preventing deaths, and as much as 57% faster than the German approach, which was based primarily on age and specific diseases. In terms of hospitalisation avoidance, the individual cumulative risk approach was 51% and 28% faster.”

According to the news reporters, the research concluded: “On this basis, it is concluded that using individual cumulative risk-based vaccination schedules, healthcare systems can be relieved and escalations more optimally avoided.”

This research has been peer-reviewed.

For more information on this research see: Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme. The European Journal of Health Economics, 2021. The European Journal of Health Economics can be contacted at: Springer, One New York Plaza, Suite 4600, New York, Ny, United States.

Our news journalists report that additional information may be obtained by contacting Danny Wende, Bifg Institute of BARMER, Wuppertal, Germany. Additional authors for this research include Dagmar Hertle, Claudia Schulte, Pedro Ballesteros and Uwe Repschlager.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1007/s10198-021-01408-8. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the The European Journal of Health Economics is: Springer, One New York Plaza, Suite 4600, New York, Ny, United States.

(Our reports deliver fact-based news of research and discoveries from around the world.)